Lepu Medical Technology (Beijing) Co., Ltd., Chinese medical device company, forays into Indian medical devices and equipment market with an overseas subsidiary company, Lepucare (India) Vascular Solutions Pvt. Ltd., which is the Fifth overseas subsidiary of the company, globally.
At a press conference at Hyderabad vice president, Lepu Medical Aaron Lin, announced Lepu Medical’s India entry and their plans for the country. Harrison Wang, managing director, Lepu India, Victor, GM, Lepu India and Jitendra R Kulkarni, director sales, Lepu India, were also present at the event.
Established in 1999, Lepu Medical specialises in developing, manufacturing and distribution of high-tech medical devices, equipment, mobile medical service and pharmaceutical. It is dedicated to reach its state-of-the-art technologies and services to patients and doctors, through its global foot print.
Lepu will set up a fully functional operation organization with 95% Indian employees. It will be launching the whole range of PCI products and bring its the structure heart products and others’ in the near future in a staggered manner. The products being launched will be made available across the length and breadth of the country.
“India has grown into one of the prime markets for medical devices and equipment, the demand here will far outstrip that of the current leading markets in America and Europe. Our entry into India, we consider is at an opportune time and will ensure arrival of the most innovative technology while making the market highly competitive through our affordable products,” said Aaron Lin.
“Our products are world class and reliable, while being within the affordable reach of the Indian patient. Our India office will be located in New Delhi and will set up branch offices in other cities depending on the operational requirement,” said Jitendra R Kulkarni.
Lepu Medical, which is a global player in the medical devices and equipment market, has four other overseas subsidiaries companies in United States, Netherlands, France and Turkey. It has presence with products in all major medical specialties including cardiovascular, neurovascular and peripheral vascular interventions, structural heart diseases, surgical cardiology, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics and general surgery
